Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
X-linked intellectual disability-macrocephaly-macroorchidism syndrome is characterized by intellectual deficit affecting both sexes, macrocephaly, and macroorchidism in the majority of affected males. It has been described in 12 individuals from two generations of one family. Other males from this family did not display intellectual deficit but did present macroorchidism and macrocephaly. Transmission is X-linked and the causative gene has been localized to the q12-q21 region of the X chromosome.
Features include very common findings: Macroorchidism, Macrocephaly, and Moderate intellectual disability.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Head and neck | 1 | Macrocephaly |
Brain and nerves | 1 | Moderate intellectual disability |
Biomarker and diagnostic research for X-linked intellectual disability-macrocephaly-macroorchidism syndrome has been reported in the published literature.
Phenotype severity distribution: 3 very common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
3 clinical trials registered, 1 recruiting. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE2, 1 PHASE1. Research is primarily sponsored by academic and government institutions.
300 publications have been identified in PubMed for X-linked intellectual disability-macrocephaly-macroorchidism syndrome. Kisho has analyzed 99 by research type. Research spans Basic Science / Preclinical (35%), Review / Meta-Analysis (25%), and Case Report / Case Series (22%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 5:51 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about X-linked intellectual disability-macrocephaly-macroorchidism syndrome
35% |
Research summaries | 25 | 25% |
Patient case studies | 22 | 22% |
Disease patterns and progression | 10 | 10% |
New treatment approaches | 3 | 3% |
Testing and diagnosis research | 2 | 2% |
Clinical study results | 2 | 2% |
Tripathi M (2026). [PMID: 36256770](https://pubmed.ncbi.nlm.nih.gov/36256770/). *Unknown Journal*. [Case Report / Case Series]
Alexander JL (2026). [PMID: 41346295](https://pubmed.ncbi.nlm.nih.gov/41346295/). *Blood Adv*. [Epidemiology / Natural History]
Proteau-Lemieux M (2026). [PMID: 41657078](https://pubmed.ncbi.nlm.nih.gov/41657078/). *Autism Res*. [Epidemiology / Natural History]
Zhao Y (2026). [PMID: 41705901](https://pubmed.ncbi.nlm.nih.gov/41705901/). *Prenat Diagn*. [Review / Meta-Analysis]
Boelaert K (2026). [PMID: 41508830](https://pubmed.ncbi.nlm.nih.gov/41508830/). *J Clin Endocrinol Metab*. [Review / Meta-Analysis]
Weissgold S (2026). [PMID: 42028919](https://pubmed.ncbi.nlm.nih.gov/42028919/). *J Intellect Disabil Res*. [Review / Meta-Analysis]
Sidorina A (2026). [PMID: 41429203](https://pubmed.ncbi.nlm.nih.gov/41429203/). *J Lipid Res*. [Diagnostic / Biomarker]
Azar I (2025). [PMID: 40330142](https://pubmed.ncbi.nlm.nih.gov/40330142/). *JCO Oncol Adv*. [Basic Science / Preclinical]
Grover A (2025). [PMID: 40057424](https://pubmed.ncbi.nlm.nih.gov/40057424/). *Best Pract Res Clin Endocrinol Metab*. [Review / Meta-Analysis]
Akaba Y (2025). [PMID: 40382977](https://pubmed.ncbi.nlm.nih.gov/40382977/). *Brain Dev*. [Review / Meta-Analysis]